Paola Candeloro

2.3k total citations · 1 hit paper
25 papers, 1.8k citations indexed

About

Paola Candeloro is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Paola Candeloro has authored 25 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Surgery and 11 papers in Genetics. Recurrent topics in Paola Candeloro's work include Diabetes Management and Research (16 papers), Pancreatic function and diabetes (12 papers) and Diabetes and associated disorders (11 papers). Paola Candeloro is often cited by papers focused on Diabetes Management and Research (16 papers), Pancreatic function and diabetes (12 papers) and Diabetes and associated disorders (11 papers). Paola Candeloro collaborates with scholars based in Italy, Germany and Sweden. Paola Candeloro's co-authors include Alberto Falorni, Filippo Calcinaro, Maria Laura Belladonna, Paolo Puccetti, Carmine Vacca, Roberta Bianchi, Maria C. Fioretti, Ursula Grohmann, Ciriana Orabona and Francesca Fallarino and has published in prestigious journals such as Nature Immunology, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Paola Candeloro

25 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CTLA-4–Ig regulates tryptophan catabolism in vivo

2002 920 citations Ursula Grohmann, Ciriana Orabona et al. Nature Immunology profile →

Peers

Countries citing papers authored by Paola Candeloro

Since Specialization

Citations

This map shows the geographic impact of Paola Candeloro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paola Candeloro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paola Candeloro more than expected).

Fields of papers citing papers by Paola Candeloro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paola Candeloro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paola Candeloro. The network helps show where Paola Candeloro may publish in the future.

Co-authorship network of co-authors of Paola Candeloro

This figure shows the co-authorship network connecting the top 25 collaborators of Paola Candeloro. A scholar is included among the top collaborators of Paola Candeloro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paola Candeloro. Paola Candeloro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacokinetic and Pharmacodynamic Head-to-Head Comparison of Clinical, Equivalent Doses of Insulin Glargine 300 units · mL−1 and Insulin Degludec 100 units · mL−1 in Type 1 Diabetes 2020 ·Diabetes Care ·Paola Lucidi, Paola Candeloro, Patrizia Cioli, Anna Marinelli Andreoli, Chiara Pascucci, Angela Gambelunghe, Geremia B. Bolli, Carmine G. Fanelli, Francesca Porcellati	18
2	Greater Suppression of Glucagon, Lipolysis, and Ketogenesis with Insulin Glargine U300 as Compared with Glargine U100 in Type 1 Diabetes Mellitus 2019 ·Diabetes Technology & Therapeutics ·Paola Lucidi, Francesca Porcellati, Patrizia Cioli, Paola Candeloro, Anna Marinelli Andreoli, Geremia B. Bolli, Carmine G. Fanelli	8
3	1088-P: A PK/PD and Metabolic Head-to-Head Comparison of Clinical Doses of Insulin Glargine U300 and Degludec in Type 1 Diabetes 2019 ·Diabetes ·Paola Lucidi, Francesca Porcellati, Paola Candeloro, Patrizia Cioli, Chiara Pascucci, Geremia B. Bolli, Carmine G. Fanelli	1
4	Pharmacokinetics, Pharmacodynamics, and Modulation of Hepatic Glucose Production With Insulin Glargine U300 and Glargine U100 at Steady State With Individualized Clinical Doses in Type 1 Diabetes 2018 ·Diabetes Care ·Francesca Porcellati, Paola Lucidi, Paola Candeloro, Patrizia Cioli, Anna Marinelli Andreoli, (unknown), Geremia B. Bolli, Carmine G. Fanelli	35
5	Different insulin concentrations in resuspended vs. unsuspended NPH insulin: Practical aspects of subcutaneous injection in patients with diabetes 2017 ·Diabetes & Metabolism ·Paola Lucidi, Francesca Porcellati, Annalisa Andreoli, Paola Candeloro, Patrizia Cioli, Geremia B. Bolli, Carmine G. Fanelli	3
6	Glargine metabolism over 24 h following its subcutaneous injection in patients with type 2 diabetes mellitus: A dose–response study 2014 ·Nutrition Metabolism and Cardiovascular Diseases ·Paola Lucidi, Francesca Porcellati, Paola Candeloro, Patrizia Cioli, Annalisa Andreoli, Stefania Marzotti, Ronald Schmidt, Geremia B. Bolli, Carmine G. Fanelli	19
7	Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes Mellitus 2011 ·Diabetes Care ·Francesca Porcellati, Paola Lucidi, Paolo Rossetti, Paola Candeloro, Anna Marinelli Andreoli, Stefania Marzotti, Patrizia Cioli, Geremia B. Bolli, Carmine G. Fanelli	16
8	Pharmacokinetics and Pharmacodynamics of Therapeutic Doses of Basal Insulins NPH, Glargine, and Detemir After 1 Week of Daily Administration at Bedtime in Type 2 Diabetic Subjects 2011 ·Diabetes Care ·Paola Lucidi, Francesca Porcellati, Paolo Rossetti, Paola Candeloro, Patrizia Cioli, Stefania Marzotti, Anna Marinelli Andreoli, (unknown), Geremia B. Bolli, Carmine G. Fanelli	46
9	Mechanisms of Insulin Resistance After Insulin-Induced Hypoglycemia in Humans: The Role of Lipolysis 2010 ·Diabetes ·Paola Lucidi, Paolo Rossetti, Francesca Porcellati, Simone Pampanelli, Paola Candeloro, Anna Marinelli Andreoli, G. Perriello, Geremia B. Bolli, Carmine G. Fanelli	36
10	High Serum Inhibin Concentration Discriminates Autoimmune Oophoritis from Other Forms of Primary Ovarian Insufficiency 2008 ·The Journal of Clinical Endocrinology & Metabolism ·(unknown), Stefania Marzotti, (unknown), Annalisa Brozzetti, Fernando M. Reis, Paola Candeloro, (unknown), Vittorio Bini, Felice Petraglia, Alberto Falorni	39
11	Effect of Oral Amino Acids on Counterregulatory Responses and Cognitive Function During Insulin-Induced Hypoglycemia in Nondiabetic and Type 1 Diabetic People 2008 ·Diabetes ·Paolo Rossetti, Francesca Porcellati, (unknown), Paola Candeloro, Patrizia Cioli, K. Sreekumaran Nair, Fausto Santeusanio, Geremia B. Bolli, Carmine G. Fanelli	24
12	Different Brain Responses to Hypoglycemia Induced by Equipotent Doses of the Long-Acting Insulin Analog Detemir and Human Regular Insulin in Humans 2007 ·Diabetes ·Paolo Rossetti, Francesca Porcellati, (unknown), Paola Candeloro, Patrizia Cioli, Geremia B. Bolli, Carmine G. Fanelli	23
13	MICA Gene Polymorphism in the Pathogenesis of Type 1 Diabetes 2007 ·Annals of the New York Academy of Sciences ·Giovanni Gambelunghe, (unknown), Mehran Ghaderi, Paola Candeloro, (unknown), Alberto Falorni	24
14	Mapping of Human Autoantibody Epitopes on Aromaticl-Amino Acid Decarboxylase 2007 ·The Journal of Clinical Endocrinology & Metabolism ·Paola Candeloro, Carla Borri Voltattorni, Roberto Perniola, Mariarita Bertoldi, Corrado Betterle, Massimo Mannelli, Roberta Giordano, Annamaria De Bellis, Claudio Tiberti, Stefano Laureti, Fausto Santeusanio, Alberto Falorni	4
15	Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse 2005 ·Diabetologia ·Filippo Calcinaro, S. Dionisi, Mariarosaria Marinaro, Paola Candeloro, V. Bonato, Stefania Marzotti, (unknown), Elisabetta Ferretti, Alberto Gulino, Felicia Grasso, Claudio De Simone, Umberto Di Mario, Alberto Falorni, Monica Boirivant, Francesco Dotta	257
16	Dehydroepiandrosterone, 17α‐hydroxyprogesterone and aldosterone responses to the low‐dose (1 µg) ACTH test in subjects with preclinical adrenal autoimmunity 2002 ·Clinical Endocrinology ·Stefano Laureti, Paola Candeloro, (unknown), Roberta Giordano, Emanuela Arvat, Ezio Ghigo, Fausto Santeusanio, Alberto Falorni	20
17	CTLA-4–Ig regulates tryptophan catabolism in vivo breakdown → 2002 ·Nature Immunology ·Ursula Grohmann, Ciriana Orabona, Francesca Fallarino, Carmine Vacca, Filippo Calcinaro, Alberto Falorni, Paola Candeloro, Maria Laura Belladonna, Roberta Bianchi, Maria C. Fioretti, Paolo Puccetti	920
18	Steroid-cell autoantibodies are preferentially expressed in women with premature ovarian failure who have adrenal autoimmunity 2002 ·Fertility and Sterility ·Alberto Falorni, Stefano Laureti, Paola Candeloro, Silvia Perrino, Concetta Coronella, Antonio Bizzarro, Antonio Bellastella, Fausto Santeusanio, Annamaria De Bellis	80
19	Low dose (1 μg) ACTH test in the evaluation of adrenal dysfunction in pre‐clinical Addison's disease 2000 ·Clinical Endocrinology ·Stefano Laureti, Emanuela Arvat, Paola Candeloro, Lidia Di Vito, Ezio Ghigo, Fausto Santeusanio, Alberto Falorni	46
20	Autoantibody Recognition of COOH-Terminal Epitopes of GAD65 Marks the Risk for Insulin Requirement in Adult-Onset Diabetes Mellitus¹ 2000 ·The Journal of Clinical Endocrinology & Metabolism ·Alberto Falorni, Giovanni Gambelunghe, (unknown), Georgia Kassi, (unknown), Paola Candeloro, Geremia B. Bolli, Paolo Brunetti, Filippo Calcinaro	63

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact